-
Loading metrics
Open Access
Peer-reviewed
Research Article
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases
-
Charles L. Bennett ,
Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: charlesleebennett@gmail.com
Affiliations Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America, Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Joseph Magagnoli ,
Roles Writing – review & editing
¶‡ JM is co-first author on this work.
Affiliation Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Krishna Gundabolu,
Roles Writing – review & editing
Affiliation Division of Hematology/Oncology, Department of Internal Medicine, Omaha School of Medicine University of Nebraska, Omaha, Nebraska, United States of America
⨯ -
Peter Georgantopoulos,
Roles Project administration, Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Akida Lebby,
Roles Project administration, Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Gretchen Watson,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Kevin Knopf,
Roles Conceptualization, Writing – review & editing
Affiliations Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America, Hematology/Oncology, Highland Hospital, Alameda Health System, Oakland, California, United States of America
⨯ -
Linda Martin,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Kenneth R. Carson,
Roles Writing – review & editing
Affiliations Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America, Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine Northwestern University, Chicago, Illinois, United States of America
⨯ -
William J. Hrushesky,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Chadi Nabhan,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Edward Zyszkowski,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Edward B. Smith,
Roles Writing – review & editing
Affiliation Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America
⨯ -
Robert Peter Gale,
Roles Conceptualization, Writing – review & editing
Affiliation Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
⨯ -
Steven T. Rosen
Roles Conceptualization, Writing – review & editing
Affiliation City of Hope Comprehensive Cancer Center and the Beckman Research Institute, Duarte, California, United States of America
⨯
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases
- Charles L. Bennett,
- Joseph Magagnoli,
- Krishna Gundabolu,
- Peter Georgantopoulos,
- Akida Lebby,
- Gretchen Watson,
- Kevin Knopf,
- Linda Martin,
- Kenneth R. Carson,
- William J. Hrushesky
- Published: September 25, 2024
- https://doi.org/10.1371/journal.pone.0308205